Fibrocystic Breast Disease

Also known as: Breast Fibrocystic Disease / Fibrocystic Disease of Breast / Diffuse cystic mastopathy / Breast dysplasia / Fibrocystic disease of breast (disorder) / Disease fibrocystic breast / Breast fibrocystic change / Breast fibrocystic disorder / Breast fibrocystic / Fibrocystic breast / Benign mammary dysplasia / Breast cystic fibrosis / Disease cystic breast / Cystic Breast Disease / Chronic Cystic Mastitis

Drug	Drug Name	Drug Description
DB01406	Danazol	A synthetic steroid and pituitary gonadotropin inhibitor used in the treatment of endometriosis and symptomatic treatment of severe pain and tenderness associated with benign fibrocystic breasts.

Drug	Drug Name	Target	Type
DB01406	Danazol	Estrogen receptor alpha	target
DB01406	Danazol	Gonadotropin-releasing hormone receptor	target
DB01406	Danazol	Putative gonadotropin-releasing hormone II receptor	target
DB01406	Danazol	Sex hormone-binding globulin	carrier
DB01406	Danazol	C-C motif chemokine 2	target
DB01406	Danazol	Cytochrome P450 19A1	enzyme
DB01406	Danazol	Androgen receptor	target
DB01406	Danazol	Progesterone receptor	target
DB01406	Danazol	Cytochrome P450 3A4	enzyme

Drug	Drug Name	Phase	Status	Count
DB01406	Danazol	2	Completed	1
DB05382	Iodine	3	Unknown Status	1
DB11358	Evening primrose oil	4	Completed	1
DB00675	Tamoxifen	4	Completed	1